MiNK Therapeutics, Inc. - COM NEW (INKT)

CUSIP: 603693201

Q2 2026 13F Holders as of 30 Jun 2026

Share change
+2
SEC-reported price per share
$11.62
Number of holders
2
Value change
+$23
Number of buys
1

Security key

603693201

Report period

Q2 2026

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of INKT - MiNK Therapeutics, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AGENUS INC
Disclosed value leader
AGENUS INC
Comparable rows
0/15
Latest evidence
04 Jun 2026
3/4/5 13F Highest disclosed value: $22,643,778 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

AGENUS INC has the largest disclosed position value at $22.64M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AGENUS INC's linked filing trail.
Disclosed position value Top 5
AGENUS INC $22.64M
Garo H. Armen $2.05M
Jennifer Buell $644.3K
VANGUARD CAPITAL MANAGEMENT LLC $625.1K
Brian Corvese $559.5K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AGENUS INC
3/4/5
10%+ Owner
class O/S missing
$22,643,778
21,772,863 shares
12 Oct 2023
Garo H. Armen
3/4/5
Director
class O/S missing
$2,045,056
1,966,400 shares
05 May 2023
Jennifer Buell
3/4/5
Chief Executive Officer
mixed-class rows
$644,315
107,942 shares
mixed-class rows
02 Jan 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
class O/S missing
$625,103
59,364 shares
31 Mar 2026
Brian Corvese
3/4/5
Director
mixed-class rows
$559,532
58,532 shares
mixed-class rows
02 Mar 2026
Ulf Wiinberg
3/4/5
Director
mixed-class rows
$546,025
55,875 shares
mixed-class rows
02 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
6
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
23
Q2 2026 holders
2
Holder diff
-21
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .